Chinanews.net March 30 Xin Guobin, Deputy Minister of Industry and Information Technology, pointed out on March 30 that China has more than 1,500 API manufacturers, the world's largest API producer, and the world's largest API exporter. Judging from the current situation, the resumption and re-production rates of the national drug substance industry chain and the main products have reached over 80%, and the output of some varieties has exceeded the level of the same period last year, especially the anti-epidemic drugs, which have been the focus of supply and supply. . Therefore, this aspect can ensure international demand for epidemic resistance.
The State Council ’s joint defense and joint control machine is scheduled to hold a press conference on March 30 to introduce the situation of the resumption of production and production in the manufacturing industry. A reporter asked at the meeting: China is a major producer of APIs. Since the new crown epidemic, what measures have we taken to ensure the supply of APIs in the domestic and international markets?
Xin Guobin introduced that China has more than 1,500 API manufacturers and is the world's largest API producer and the world's largest API exporter. In normal years, China's raw material output is about 3 million tons, and exports are about 1 million tons. Our country is the world's largest producer and exporter of vitamins, antibiotics, antipyretic and analgesics, anti-infective drugs, and sebum hormone drugs, etc., and their share in the international market is more than 50%. Raw material medicine is the upstream of the therapeutic drug industry chain, and it is a foundation for ensuring the supply of medicines and meeting the needs of people. Therefore, during the epidemic, we attach great importance to the production of raw materials.
Xin Guobin mentioned that during the critical period of epidemic prevention and control, the Ministry of Industry and Information Technology received some preparations companies reflecting that Hubei's upstream API companies have not resumed work. The raw material markets such as bezoar, metronidazole, ibuprofen, and taurine have been urgent, directly affecting some Production and supply issues for pharmaceutical products. After receiving the response, the Ministry of Industry and Information Technology urgently coordinated the relevant departments of Hubei Province, provinces, cities and counties to carry out key scheduling for some API manufacturers, requiring them to overcome difficulties and actively organize employees to return to work. After the request was made in late February, it took less than a week or so for the Ministry of Industry and Information Technology to prompt these enterprises to resume work and resume production, effectively guarantee the production of pharmaceutical preparations, and make due contributions to the prevention and control of the epidemic.
Xin Guobin pointed out that at present, the new crown pneumonia epidemic is spreading rapidly around the world, which has also affected the production and supply of medicines. Some countries now reflect that the supply of APIs is a bit tight, mainly due to several factors: First, this year 1 In February and February, due to the impact of the epidemic, some companies stopped production and production, and there was a shortfall in supply. Second, after February, international transportation, especially shipping and maritime transportation, was greatly restricted and affected due to the spread of the international epidemic, which caused some logistics and transportation problems to occur and transportation difficulties.
Xin Guobin pointed out that China, as a responsible big country, attaches great importance to the safety of the global pharmaceutical industry supply chain. We will work hard to maintain the production of API manufacturers and ensure the safety and stability of global industry chain supply. Judging from the current situation, the resumption and re-production rates of the country's bulk drug industry chain and the main products' yields have exceeded 80%, and the output of some varieties has exceeded the level of the same period last year, especially the anti-epidemic drugs, which have been guaranteed. Focus. Therefore, international anti-epidemic needs can be guaranteed in this regard.
In the next step, the Ministry of Industry and Information Technology will also organize the implementation of monitoring and production scheduling of key products, coordinate the solution of export transportation difficulties encountered by enterprises, strengthen communication and docking with WHO, foreign business associations, and multinational pharmaceutical companies, and organize targeted enterprises. The development of supply services to ensure domestic and international market supply and make due contributions to the fight against the epidemic worldwide.